Work

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials

Year: 2011

Type: article

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2011.10.021

Authors: Joseph Treat, Giorgio V. Scagliotti, Guangbin Peng, Matthew J. Monberg, Coleman K. Obasaju, Mark A. Socinski

Institutions: Eli Lilly (United States), Ospedale San Luigi Gonzaga, University of Turin, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Eli Lilly and Company

OpenAlex ID: W2076315677

FWCI: 3.807

Cites: 29

Cited by: 48

Related to: 10